Profile: Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing oral drugs for patients with serious diseases & disorders such as obesity and insomnia. Our lead proprietary drug candidate, lorcaserin hydrochloride is intended for the treatment of obesity. We also develop APD125, an oral drug candidate being evaluated for the treatment of insomnia.
2 Products/Services (Click for related suppliers)
| |||||
• | Biopharmaceutical Service | • | Lorcaserin Hydrochloride |